1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of genetic alterations from the bladder cancer genome atlas (TCGA) and a prospective set of high-grade urothelial carcinoma tumors using a CLIA laboratory next generation sequencing assay
    Meeting Abstract

    Iyer, G.; Bagrodia, A.; Cha, E. K.; Boyd, M. E.; Zehir, A.; Cheng, D. T.; Hyman, D. M.; Bambury, R. M.; Arcila, M. E.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase 2 study of the pan-isoform PI3 kinase inhibitor BKM120 in metastatic urothelial carcinoma patients
    Meeting Abstract

    Iyer, G.; Tully, C. M.; Garcia-Grossman, I. R.; Scott, S. N.; Boyd, M. E.; McCoy, A. S.; Berger, M. F.; Al-Ahmadie, H.; Solit, D. B.; Rosenberg, J. E.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Association of genome-wide copy number alterations with metastasis of clear cell renal cell carcinoma
    Meeting Abstract

    Gowrishankar, B.; Thodima, V. J.; Molina, A. M.; Ma, C.; Guttapalli, A.; Gold, T. M.; Motzer, R. J.; Chaganti, R. S. K.; Houldsworth, J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Split-dose cisplatin as an alternative to every-3-week dosing when using cisplatin/gemcitabine to treat advanced urothelial
    Meeting Abstract

    Gonzalez, C. M.; Jordan, E.; Zabor, E. C.; Kania, B. E.; Regazzi, A. M.; Ostrovnaya, I.; Iyer, G.; Bajorin, D. F.; Bambury, R. M.; Rosenberg, J. E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Cardiovascular disease (CVD) risk factors among cisplatin-treated testicular cancer survivors (TCS): A multicenter clinical study of US and Canadian patients
    Meeting Abstract

    Fung, C.; Feldman, D. R.; Hamilton, R. J.; Case-Eads, S.; Vaughn, D. J.; Beard, C.; Moore, M. J.; Sahasrabudhe, D. M.; Brames, M. J.; Fossa, S. D.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Assessment of corticosteroid (CS)-associated adverse events (AEs) with long-term (LT) exposure to low-dose prednisone (P) given with abiraterone acetate (AA) to metastatic castration-resistant prostate cancer (mCRPC) patients (Pts)
    Meeting Abstract

    Fizazi, K.; Chi, K. N.; de Bono, J. S.; Gomella, L. G.; Miller, K.; Rathkopf, D. E.; Ryan, C. J.; Scher, H. I.; Shore, N. D.; De Porre, P.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591
    Meeting Abstract

    Feldman, J. L.; Morris, M. J.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; O'Donoghue, J. A.; Martinez, D. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Response to taxane chemotherapy as first subsequent therapy after abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Post-hoc analysis of COU-AA-302
    Meeting Abstract

    de Bono, J. S.; Smith, M. R.; Saad, F.; Rathkopf, D. E.; Mulders, P. F. A.; Small, E. J.; Shore, N. D.; Fizazi, K.; De Porre, P.; San Kheoh, T.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Clonality of bladder tumors following radical nephroureterectomy: Against the field defect hypothesis
    Meeting Abstract

    Cha, E. K.; Sfakianos, J.; Scott, S. N.; Murugan, P.; Iyer, G.; Bagrodia, A.; Shah, R.; Bajorin, D. F.; Rosenberg, J. E.; Berger, M. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Final analysis COMET-2: Cabozantinib (Cabo) versus mitoxantrone/prednisone (MP) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) with moderate to severe pain who were previously treated with docetaxel(D) and abiraterone (A) and/or enzalutamide (E)
    Meeting Abstract

    Basch, E. M.; Sholz, M. C.; de Bono, J. S.; Vogelzang, N. J.; De Souza, P. L.; Marx, G. M.; Vaishampayan, U. N.; George, S.; Schwarz, J. K.; Antonarakis, E. S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save